Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol.
Yasui-Furukori
N
N
Kondo
T
T
Suzuki
A
A
Mihara
K
K
Tokinaga
N
N
Inoue
Y
Y
Otani
K
K
Kaneko
S
S
D000328:Adult; D000368:Aged; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005260:Female; D005838:Genotype; D006220:Haloperidol / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000235:genetics*
D011388:Prolactin; D019389:Cytochrome P-450 CYP2D6; D006220:Haloperidol